Shelley Rahe

Here's an article that dives a little deeper into the DPE takeaway focused on patient adherence and prescription abandonment. IPG Health SOLVE(D) | An IPG Health Company

19

1 Comment

When we think about advancements in leadership and innovation in healthcare, we’re seeing medical affairs develop their growing social media followings. Distinct from corporate accounts, these teams define what’s important to them and share it with their followers. But other medical affairs teams remain reluctant—and that’s a shame because they are missing out on the chance to connect with the HCPs, patients, and care partners who are active online and conducting their own research. That's why the SOMEMA Index created by Tim Mitchell, Managing Director of Medical Communications & Innovation, Klick Health, is essential. It provides a clear framework for medical affairs to quantify and enhance their social media outreach, ensuring strategic growth that aligns with our industry’s goals. Tim explains his rationale here and this article includes: - The rising significance of individualized social media platforms within medical affairs - The necessity for robust measurement strategies to guide social media engagement - The potential of social media to foster deeper connections with the medical community Learn more about the impact of SOMEMA and how it can transform your approach here: https://bit.ly/3UaQNHv

22

Throughout my career, I have learned valuable lessons from observing leaders. These lessons have helped shape my skills as a mentor and leader. #AlwaysLearning

9

2 Comments

Rare disease hits too close to home– for too many. As healthcare marketers, we feel it's crucial to connect with patients on their own terms. Let's aim to empower patients and foster a supportive rare disease community. https://okt.to/q8cRCj #patientengagement #healthcaremarketing #rarediseasesupport #psp #healthcarestrategies

1

🌟Take some time to read this report… we will all live longer but are we well prepared? 𝘈𝘨𝘪𝘯𝘨 𝘞𝘦𝘭𝘭 𝘪𝘯 𝘈𝘮𝘦𝘳𝘪𝘤𝘢: 𝘈𝘈𝘙𝘗’𝘴 𝘝𝘪𝘴𝘪𝘰𝘯 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘕𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘗𝘭𝘢𝘯 𝘰𝘯 𝘈𝘨𝘪𝘯𝘨: the report outlines clear goals along with actionable policy opportunities. 👇🏾Read more below #Agewell #NationalPlanOnAging #AARPPolicy #Research, #ThoughtLeadership #AARPResearch

11

1 Comment

In the ever-diversifying world of pharmaceuticals, understanding and embracing multicultural marketing is more crucial than ever. Fast Company highlights how the industry is shifting its strategies to address the unique needs of diverse communities effectively. 📊 Key Insights: - Inclusive Research & Development: Pharmaceutical companies are recognizing the importance of including diverse populations in clinical trials to ensure treatments are effective across all demographics. - Cultural Competence: Developing marketing campaigns that resonate culturally and linguistically with different communities is becoming a top priority. - Community Engagement: Partnering with community leaders and organizations to build trust and awareness about health issues and available treatments. - Digital Health Solutions: Leveraging technology to provide accessible healthcare information and services tailored to various cultural groups. 🌟 Embracing these strategies isn't just good practice—it's essential for building a healthcare system that truly serves everyone. By prioritizing inclusivity and cultural sensitivity, we can create more effective marketing campaigns and foster better health outcomes for all communities. #Pharmaceuticals #MulticulturalMarketing #HealthcareInnovation #InclusiveMarketing #DiversityInHealthcare

5

On the topic of Women's Health - we're talking more and more about it. We all know women face unique healthcare challenges. In this piece my colleague explores the disparities in women's health and advocate for digital solutions and personalized care to bridge the gap. Discover how healthcare organizations can transform women's healthcare and improve outcomes for entire communities. #WomensHealth #HealthEquity #DigitalHealth #PatientCare https://bit.ly/3ymyeYU

14

Pleased to share insights from the patient advocacy community on what a good partnership with pharma looks like. Definitely worth a read and please DM me if you are from either a patient group or pharma company and would be interested in contributing to the 2025 guide #patientpartnerships #patientorganisations #medcomms

11

If any industry should be human-centric, it's healthcare. For anyone in a healthcare-related industry, check out our upcoming webinar on how to practically incorporate a greater degree of patient-centricity into your approach.

1

Did you know that more than 80% of medical records consists of unstructured data such as genomics reports, imaging, labs, and clinician notes? With our recent partnership with Deep 6 AI the ability to glean clinical insights from that untapped percentage is now much easier through their AI/NLP technology and Magnolia Market Access HEOR/RWE expertise. Register below for next Thursday's webinar on this very topic and how you can gain access to these insights.

2

As always, well-reported and well-written insights from Jack O'Brien on the healthcare marketing agency landscape heading into 2025. We'll see what happens, but I am skeptical that an agency mega-merger, inevitably followed by layoffs, is going to help clients.

2

Immunotherapy, precision medicine, biomarkers, and pharmacist engagement...oh my! Signficant science and practice focus on delivering value and improving outcomes. Come join us for these conversations and more! Hit me up if you have questions. #oncology #IVBM #AJMC #evidencebasedmedicine #Boston #valuebasedcare

6

Marketing without measurement is like sailing without a compass. In today’s fast-paced world, waiting for an ROI study post-campaign is so 2009. Join the #IQVIA webinar “Our Resident Data Nerd Spills the Tea: Confessions from a Methodologist” on September 19, 2024 at 2p.m. ET, where measurement experts will address: -Why pharma values measurement and the metrics that matter most. -Key considerations when choosing a measurement partner and spotting red flags -How to identify and address inaccurate or inconsistent analytics results -Best practices for obtaining actionable measurement insights. https://lnkd.in/geQVrV7N

18

It's important for every brand to understand its purpose and to express it through the 3 Essential Narratives and an authentic and resonant storytelling framework.

14

In the evolving landscape of #HealthcareMarketing, the #DTC approach presents both unprecedented opportunities and significant challenges. Join us on May 29 to hear from @David Reim and @Luk Arbuckle as they discuss increasing concern over the potential to identify individuals when health data is combined with consumer data. Learn more and register here: https://lnkd.in/eEvvuDWF

9

Doctors’ Emotional Connections…to Prescription Drug Brands? As residents of a brand-saturated culture, we all know how important brands are in our lives. For example, and to be extremely specific, the Pantone green shade (PMS 3425 C) of the Starbucks logo has a positive visceral effect on me. This reaction is triggered, no doubt, by the conditioning effects of their powerfully caffeinated beverages on dopamine release in my brain over the course of a lifetime. When it comes to patients, it is easy to understand how someone could come to love a medication, based on how quickly and reliably it relieves their distressing symptoms. Conversely, many people come to hate a medication, because of the burdensome nature of the dosing, the taste of the liquid, or the unpleasant side effects. But what about doctors? Are prescription drugs simply simply tools of their trade that they view in a neutral, dispassionate manner? I think not. I maintain that doctors can have strong emotional reactions to Rx medications. When I practiced emergency medicine, there were some medications in which I had great confidence and which I enjoyed administering because of how well, how quickly, and how consistently they worked. IV adenosine for supraventricular tachycardia comes to mind. Being able to control an SVT instantly with a simple injection made me feel wonderful, powerful, almost god-like. Other medications made me uncomfortable through repeated associations with negative situations. For example, ketorolac (an injectable NSAID) was introduced with great fanfare as a potent non-opioid pain reliever. But, as soon as we started using it, patients whom we suspected of drug-seeking behavior claimed to be allergic to it. This led to a series of stressful and contentious encounters in our emergency department. And consider the challenging matter of drug compliance. How often do doctors prescribe medications while suspecting, in the back of their minds, that their patient will not take the drug as recommended because its dosing schedule is unrealistic? How does that make doctors feel? Then there are the high-priced treatments that the doctor knows, even as they prescribe the medication through the EHR, will lead to pushback from the payor based on cost or prior authorization requirements, leading to additional paperwork and treatment delays. These are just a few examples of a curious, sometimes impactful, though rarely discussed, emotional aspect of being a prescriber.

2